Charles W. Newton - Jun 3, 2024 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ Bryan McMichael, as Attorney-in-Fact for Charles W. Newton
Stock symbol
CHRS
Transactions as of
Jun 3, 2024
Transactions value $
$0
Form type
4
Date filed
6/5/2024, 06:52 PM
Previous filing
Mar 25, 2024
Next filing
Jun 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +112K $0.00 112K Jun 3, 2024 Common Stock 112K $1.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.